Fourth Quarter Highlights
(all comparisons made to the
- Net sales of
$3 billion with 4 percent organic volume growth - Operating income of
$349 million - Operating EBITDA up 18 percent to
$586 million - Net income per diluted share of
$1.44 - Adjusted net income per diluted share increase of 77 percent to
$1.59
Fiscal Year Highlights
(all comparisons made to fiscal year 2019)
- Net sales of
$11.7 billion with 2 percent organic volume growth - Operating income up 21 percent to
$1.2 billion - Operating EBITDA up 41 percent to
$2.2 billion - Net income per diluted share up 38 percent to
$4.14 - Adjusted net income per diluted share increase of 42 percent to
$4.85 RPC Group Plc (“RPC”) integration and synergy realization progressing better than plan- Exceeded guidance for both cash flow from operations and free cash flow, recording
$1.5 billion and$947 million , respectively.
Berry’s Chairman and CEO,
“The execution from our front-line team members, for not only achieving our financial performance results, but also in helping keep each other safe, while meeting the critical needs of our communities and customers, was nothing short of outstanding. In the face of significant adversity and complexity across the globe, our business continued to demonstrate our financial and operational stability throughout the year.
“We enter fiscal 2021 with confidence in our ability to grow organically as we have demonstrated this past year. I believe we are well positioned to see long-term, predictable, and sustainable growth with customer-linked capital investments that target continued expansion into both faster growing end markets and developing emerging markets.”
Consolidated Overview
Net sales were essentially flat with an organic volume increase of 4 percent and a favorable impact from foreign currency changes of
The operating income decrease is primarily attributed to a
The net sales decrease in the
The operating income increase is primarily attributed to a
The net sales growth in the
The operating income increase is primarily attributed to a
Health, Hygiene, & Specialties
The net sales growth in the Health, Hygiene & Specialties segment is primarily attributed to organic volume growth of 12 percent, partially offset by lower selling prices of
The operating income decrease is primarily attributed to a
Engineered Materials
The net sales decrease in the Engineered Materials segment is primarily attributed to lower selling prices of
The operating income increase is primarily attributed to a
Fiscal Year 2020 Results
Consolidated Overview
The net sales growth is primarily attributed to acquisition net sales of
The operating income increase is primarily attributed to acquisition operating income of
The net sales growth in the
The operating income increase is primarily attributed to acquisition operating income of
The net sales growth in the
The operating income increase is primarily attributed to acquisition operating income of
Health, Hygiene, & Specialties
The net sales decrease in the Health, Hygiene & Specialties segment is primarily attributed to lower selling prices of
The operating income decrease is primarily attributed to a
Engineered Materials
The net sales decrease in the Engineered Materials segment is primarily attributed to lower selling prices of
The operating income decrease was modestly impacted by the organic volume decline and an increase in selling, general and administrative expenses. These increases were partially offset by a
Cash Flow
Our cash flow from operating activities was
Balance Sheet and Liquidity
Our total debt less cash and cash equivalents at the end of the
In fiscal 2020 the Company paid off over
Fiscal 2021 Guidance
We anticipate our fiscal year 2021 operating EBITDA to be in the range of
Investor Conference Call
The Company will host a conference call today,
About Berry
Non-GAAP Financial Measures and Estimates
This press release includes non-GAAP financial measures such as operating EBITDA, Adjusted EBITDA, Adjusted net income, and free cash flow. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in
Forward Looking Statements
Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered “forward looking” within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “projects,” “estimates,” “outlook,” “anticipates” or “looking forward,” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results.
Important factors that could cause actual results to differ materially from our expectations, which we refer to as cautionary statements, are disclosed under “Risk Factors” and elsewhere in our Annual Report on Form 10-K and subsequent filings with the
Consolidated Statements of Income (Unaudited) (in millions of dollars, except per share data amounts) |
|||||||||||||
|
Quarterly Period Ended |
|
Fiscal Year Ended |
||||||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||||||
Net sales |
$ |
3,008 |
|
$ |
3,019 |
|
|
$ |
11,709 |
|
$ |
8,878 |
|
Costs and expenses: |
|
|
|
|
|
|
|
||||||
Cost of goods sold |
|
2,342 |
|
|
2,511 |
|
|
|
9,301 |
|
|
7,259 |
|
Selling, general and administrative |
|
219 |
|
|
199 |
|
|
|
850 |
|
|
583 |
|
Amortization of intangibles |
|
74 |
|
|
75 |
|
|
|
300 |
|
|
194 |
|
Restructuring and transaction activities |
|
24 |
|
|
(164 |
) |
|
|
79 |
|
|
(132 |
) |
Operating income |
|
349 |
|
|
398 |
|
|
|
1,179 |
|
|
974 |
|
|
|
|
|
|
|
|
|
||||||
Other (income) expense, net |
|
25 |
|
|
(4 |
) |
|
|
31 |
|
|
155 |
|
Interest expense, net |
|
96 |
|
|
128 |
|
|
|
435 |
|
|
329 |
|
Income before income taxes |
|
228 |
|
|
274 |
|
|
|
713 |
|
|
490 |
|
Income tax expense |
|
33 |
|
|
45 |
|
|
|
154 |
|
|
86 |
|
Net income |
$ |
195 |
|
$ |
229 |
|
|
$ |
559 |
|
$ |
404 |
|
|
|
|
|
|
|
|
|
||||||
Net income per share: |
|
|
|
|
|
|
|
||||||
Basic |
$ |
1.47 |
|
$ |
1.73 |
|
|
$ |
4.22 |
|
$ |
3.08 |
|
Diluted |
|
1.44 |
|
|
1.70 |
|
|
|
4.14 |
|
|
3.00 |
|
|
|
|
|
|
|
|
|
||||||
Outstanding weighted-average shares: (in millions) |
|
|
|
|
|
|
|
||||||
Basic |
|
133.1 |
|
|
132.2 |
|
|
|
132.6 |
|
|
131.3 |
|
Diluted |
|
135.4 |
|
|
134.4 |
|
|
|
135.1 |
|
|
134.6 |
|
Condensed Consolidated Balance Sheets (Unaudited) (in millions of dollars) |
|||||
|
|
|
|
||
Assets: |
|
|
|
||
Cash and cash equivalents |
$ |
750 |
|
$ |
750 |
Accounts receivable, net |
|
1,469 |
|
|
1,526 |
Inventories |
|
1,268 |
|
|
1,324 |
Other current assets |
|
330 |
|
|
157 |
Property, plant, and equipment, net |
|
4,561 |
|
|
4,714 |
|
|
8,323 |
|
|
7,998 |
Total assets |
$ |
16,701 |
|
$ |
16,469 |
|
|
|
|
||
Liabilities and Stockholders' Equity: |
|
|
|
||
Current liabilities, excluding debt |
$ |
2,108 |
|
$ |
1,935 |
Current and long-term debt |
|
10,237 |
|
|
11,365 |
Other long-term liabilities |
|
2,264 |
|
|
1,551 |
Stockholders’ equity |
|
2,092 |
|
|
1,618 |
Total liabilities and stockholders' equity |
$ |
16,701 |
|
$ |
16,469 |
Condensed Consolidated Statements of Cash Flows (Unaudited) (in millions of dollars) |
|||||||
|
Fiscal Year Ended |
||||||
|
|
|
|
||||
|
|
|
|
||||
Cash flows from operating activities: |
|
|
|
||||
Net cash from operating activities |
|
1,530 |
|
|
|
1,201 |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Additions to property, plant, and equipment, net |
|
(583 |
) |
|
|
(399 |
) |
Divestiture of business |
|
— |
|
|
|
326 |
|
Acquisition of business & purchase price derivatives |
|
(14 |
) |
|
|
(6,178 |
) |
Settlement of net investment hedges |
|
281 |
|
|
|
— |
|
Net cash from investing activities |
|
(316 |
) |
|
|
(6,251 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Repayments on long-term borrowings |
|
(2,436 |
) |
|
|
(1,214 |
) |
Proceeds from long-term borrowings |
|
1,202 |
|
|
|
6,784 |
|
Proceeds from issuance of common stock |
|
30 |
|
|
|
55 |
|
Debt financing costs |
|
(16 |
) |
|
|
(87 |
) |
Repurchase of common stock |
|
— |
|
|
|
(74 |
) |
Payment of tax receivable agreement |
|
— |
|
|
|
(38 |
) |
Net cash from financing activities |
|
(1,220 |
) |
|
|
(5,426 |
) |
Effect of currency translation on cash |
|
6 |
|
|
|
(7 |
) |
Net change in cash and cash equivalents |
|
— |
|
|
|
369 |
|
Cash and cash equivalents at beginning of period |
|
750 |
|
|
|
381 |
|
Cash and cash equivalents at end of period |
$ |
750 |
|
|
$ |
750 |
|
Condensed Consolidated Financial Statements Segment Information (Unaudited) (in millions of dollars) |
||||||||||||||||
|
Quarterly Period Ended |
|||||||||||||||
|
Consumer |
|
Consumer |
|
Health, |
|
Engineered |
|
Total |
|||||||
Net sales |
$ |
1,071 |
|
$ |
746 |
|
$ |
604 |
|
|
$ |
587 |
|
$ |
3,008 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Operating income |
$ |
104 |
|
$ |
94 |
|
$ |
73 |
|
|
$ |
78 |
|
$ |
349 |
|
Depreciation and amortization |
|
78 |
|
|
60 |
|
|
44 |
|
|
|
25 |
|
|
207 |
|
Restructuring and transaction activities (1) |
|
18 |
|
|
5 |
|
|
— |
|
|
|
1 |
|
|
24 |
|
Other non-cash charges (2) |
|
2 |
|
|
1 |
|
|
1 |
|
|
|
2 |
|
|
6 |
|
Operating EBITDA |
$ |
202 |
|
$ |
160 |
|
$ |
118 |
|
|
$ |
106 |
|
$ |
586 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Quarterly Period Ended |
|||||||||||||||
|
Consumer |
|
Consumer |
|
Health, |
|
Engineered |
|
Total |
|||||||
Net sales |
$ |
1,077 |
|
$ |
744 |
|
$ |
570 |
|
|
$ |
628 |
|
$ |
3,019 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Operating income |
$ |
13 |
|
$ |
67 |
|
$ |
250 |
|
|
$ |
68 |
|
$ |
398 |
|
Depreciation and amortization |
|
82 |
|
|
59 |
|
|
46 |
|
|
|
29 |
|
|
216 |
|
Restructuring and transaction activities (1) |
|
41 |
|
|
6 |
|
|
(212 |
) |
|
|
3 |
|
|
(162 |
) |
Other non-cash charges (2) |
|
37 |
|
|
5 |
|
|
2 |
|
|
|
1 |
|
|
45 |
|
Operating EBITDA |
$ |
173 |
|
$ |
137 |
|
$ |
86 |
|
|
$ |
101 |
|
$ |
497 |
|
(1) |
The current quarter primarily includes transaction activity costs related to the RPC acquisition. The prior year quarter primarily includes the sale of our Seal for Life business of |
|
(2) |
Other non-cash charges for the |
Condensed Consolidated Financial Statements Segment Information (Unaudited) (in millions of dollars) |
||||||||||||||||
|
Fiscal Year Ended |
|||||||||||||||
|
Consumer |
|
Consumer |
|
Health, |
|
Engineered |
|
Total |
|||||||
Net sales |
$ |
4,195 |
|
$ |
2,850 |
|
$ |
2,330 |
|
|
$ |
2,334 |
|
$ |
11,709 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Operating income |
$ |
299 |
|
$ |
320 |
|
$ |
243 |
|
|
$ |
317 |
|
$ |
1,179 |
|
Depreciation and amortization |
|
318 |
|
|
250 |
|
|
172 |
|
|
|
105 |
|
|
845 |
|
Restructuring and transaction activities (1) |
|
55 |
|
|
11 |
|
|
6 |
|
|
|
7 |
|
|
79 |
|
Other non-cash charges (2) |
|
31 |
|
|
10 |
|
|
5 |
|
|
|
8 |
|
|
54 |
|
Operating EBITDA |
$ |
703 |
|
$ |
591 |
|
$ |
426 |
|
|
$ |
437 |
|
$ |
2,157 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Fiscal Year Ended |
|||||||||||||||
|
Consumer |
|
Consumer |
|
Health, |
|
Engineered |
|
Total |
|||||||
Net sales |
$ |
1,229 |
|
$ |
2,636 |
|
$ |
2,475 |
|
|
$ |
2,538 |
|
$ |
8,878 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Operating income |
$ |
12 |
|
$ |
234 |
|
$ |
410 |
|
|
$ |
318 |
|
$ |
974 |
|
Depreciation and amortization |
|
93 |
|
|
216 |
|
|
188 |
|
|
|
116 |
|
|
613 |
|
Restructuring and transaction activities (1) |
|
54 |
|
|
14 |
|
|
(198 |
) |
|
|
8 |
|
|
(126 |
) |
Other non-cash charges (2) |
|
38 |
|
|
11 |
|
|
9 |
|
|
|
11 |
|
|
69 |
|
Operating EBITDA |
$ |
197 |
|
$ |
475 |
|
$ |
405 |
|
|
$ |
453 |
|
$ |
1,530 |
|
(1) |
Restructuring and transaction activity costs for the fiscal year ended |
|
(2) |
Other non-cash charges for the fiscal year ended |
|
* Prior year has been restated to match our current structure. |
Reconciliation Schedules (Unaudited) (in millions of dollars, except per share data) |
|||||||||||||||
|
Quarterly Period Ended |
|
Fiscal Year Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Net income |
$ |
195 |
|
|
$ |
229 |
|
|
$ |
559 |
|
|
$ |
404 |
|
Add: other (income) expense, net |
|
25 |
|
|
|
(4 |
) |
|
|
31 |
|
|
|
155 |
|
Add: interest expense, net |
|
96 |
|
|
|
128 |
|
|
|
435 |
|
|
|
329 |
|
Add: income tax expense |
|
33 |
|
|
|
45 |
|
|
|
154 |
|
|
|
86 |
|
Operating income |
$ |
349 |
|
|
$ |
398 |
|
|
$ |
1,179 |
|
|
$ |
974 |
|
|
|
|
|
|
|
|
|
||||||||
Add: non-cash amortization from 2006 private sale |
|
6 |
|
|
|
7 |
|
|
|
25 |
|
|
|
28 |
|
Add: restructuring and transaction activities (1) |
|
24 |
|
|
|
(162 |
) |
|
|
79 |
|
|
|
(126 |
) |
Add: other non-cash charges (2) |
|
6 |
|
|
|
45 |
|
|
|
54 |
|
|
|
69 |
|
Adjusted operating income (8) |
$ |
385 |
|
|
$ |
288 |
|
|
$ |
1,337 |
|
|
$ |
1,240 |
|
|
|
|
|
|
|
|
|
||||||||
Add: depreciation |
|
133 |
|
|
|
141 |
|
|
|
545 |
|
|
|
419 |
|
Add: amortization of intangibles (3) |
|
68 |
|
|
|
68 |
|
|
|
275 |
|
|
|
166 |
|
Operating EBITDA (8) |
$ |
586 |
|
|
$ |
497 |
|
|
$ |
2,157 |
|
|
$ |
1,530 |
|
|
|
|
|
|
|
|
|
||||||||
Add: Unrealized synergies (4) |
|
|
|
|
|
62 |
|
|
|
||||||
Adjusted EBITDA (8) |
|
|
|
|
$ |
2,219 |
|
|
|
||||||
Cash flow from operating activities |
$ |
552 |
|
|
$ |
630 |
|
|
$ |
1,530 |
|
|
$ |
1,201 |
|
Net additions to property, plant, and equipment |
|
(165 |
) |
|
|
(128 |
) |
|
|
(583 |
) |
|
|
(399 |
) |
Payment of tax receivable agreement |
|
— |
|
|
|
(22 |
) |
|
|
— |
|
|
|
(38 |
) |
Free cash flow (8) |
$ |
387 |
|
|
$ |
480 |
|
|
$ |
947 |
|
|
$ |
764 |
|
|
|
|
|
|
|
|
|
||||||||
Net income per diluted share |
$ |
1.44 |
|
|
$ |
1.70 |
|
|
$ |
4.14 |
|
|
$ |
3.00 |
|
Other expense, net |
|
0.18 |
|
|
|
(0.03 |
) |
|
|
0.23 |
|
|
|
1.15 |
|
Non-cash amortization from 2006 private sale |
|
0.04 |
|
|
|
0.05 |
|
|
|
0.19 |
|
|
|
0.21 |
|
Restructuring and transaction activities |
|
0.18 |
|
|
|
(1.20 |
) |
|
|
0.58 |
|
|
|
(0.93 |
) |
Other non-cash charges (5) |
|
— |
|
|
|
0.29 |
|
|
|
0.14 |
|
|
|
0.29 |
|
Non-comparable tax items (6) |
|
(0.15 |
) |
|
|
— |
|
|
|
(0.15 |
) |
|
|
— |
|
Income tax impact on items above (7) |
|
(0.10 |
) |
|
|
0.09 |
|
|
|
(0.28 |
) |
|
|
(0.31 |
) |
Adjusted net income per diluted share (8) |
$ |
1.59 |
|
|
$ |
0.90 |
|
|
$ |
4.85 |
|
|
$ |
3.41 |
|
|
Estimated |
||
Cash flow from operating activities |
|
||
Additions to property, plant, and equipment |
(650) |
||
Free cash flow (8) |
|
(1) |
The current quarter primarily includes transaction activity costs related to the RPC acquisition. The prior year quarter primarily includes the sale of our Seal for Life business of |
|
(2) |
Other non-cash charges for the |
|
(3) |
Amortization excludes non-cash amortization from the 2006 private sale of |
|
(4) |
Represents unrealized cost savings related to acquisitions. |
|
(5) |
No adjustment was made only for the current quarter. An adjustment was made for the |
|
(6) |
During fiscal year 2020 the Company obtained certain tax benefits of |
|
(7) |
Income tax effects on adjusted net income is calculated using 25 percent for both the |
|
(8) |
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in |
|
We define “free cash flow” as cash flow from operating activities less additions to property, plant, and equipment and payments under the tax receivable agreement. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe free cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash. |
||
Adjusted EBITDA is used by our lenders for debt covenant compliance purposes. We also use Adjusted EBITDA and Operating EBITDA among other measures to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA and Operating EBITDA and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe EBITDA and Adjusted net income are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201119005164/en/
Company Contact:
+1 (812) 306 2964
ir@berryglobal.com
Source: